MAPK14 and breast cancer: Notably, considering the wide expression and tumorigenic function of MAPK14 across a wide variety of cancers, including breast cancer, lung cancer, and colon cancer among others, it suggests that lobeline could potentially target MAPK14 in multiple malignancies beyond CRC.